MetLife (MET) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates

In its upcoming report, MetLife (MET) is predicted by Wall Street analysts to post quarterly earnings of $2.36 per share, reflecting an increase of 13.5% compared to the same period last year. Revenues are forecasted to be $25.57 billion, representing a year-over-year increase of 29.6%.The consensus EPS estimate for the quarter has undergone a downward revision of 0.7% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.Bearing this in mind, let's now explore the average estimates of specific MetLife metrics that are commonly monitored and projected by Wall Street analysts.Analysts predict that the 'Revenue- Net investment income' will reach $5.50 billion. The estimate suggests a change of +1.7% year over year.The collective assessment of analysts points to an estimated 'Revenue- Other Revenues' of $661.92 million. The estimate indicates a year-over-year change of +3.3%.The average prediction of analysts places 'Revenue- Universal life and investment-type product policy fees' at $1.26 billion. The estimate indicates a year-over-year change of +3.4%.It is projected by analysts that the 'Adjusted Revenue- Group Benefits- Other Revenues' will reach $404.67 million. The estimate points to a change of +7.1% from the year-ago quarter.Analysts forecast 'Total Adjusted Revenue- EMEA' to reach $782.70 million. The estimate indicates a year-over-year change of +10.1%.The consensus estimate for 'Adjusted Revenue- Asia- Universal life and investment-type product policy fees' stands at $398.66 million. The estimate points to a change of -2.8% from the year-ago quarter.Analysts' assessment points toward 'Adjusted Revenue- Latin America- Universal life and investment-type product policy fees' reaching $367.09 million. The estimate indicates a change of +11.2% from the prior-year quarter.According to the collective judgment of analysts, 'Adjusted Revenue- EMEA- Universal life and investment-type product policy fees' should come in at $82.90 million. The estimate suggests a change of +9.1% year over year.Analysts expect 'Total Adjusted Revenue- Asia' to come in at $3.03 billion. The estimate points to a change of +5.1% from the year-ago quarter.The combined assessment of analysts suggests that 'Adjusted Revenue- Asia- Net investment income' will likely reach $1.38 billion. The estimate indicates a year-over-year change of +10.5%.Based on the collective assessment of analysts, 'Adjusted Revenue- EMEA- Net investment income' should arrive at $63.95 million. The estimate points to a change of +8.4% from the year-ago quarter.The consensus among analysts is that 'Adjusted Revenue- Latin America- Net investment income' will reach $428.82 million. The estimate indicates a change of -0.5% from the prior-year quarter. View all Key Company Metrics for MetLife here>>> MetLife shares have witnessed a change of -0.9% in the past month, in contrast to the Zacks S&P 500 composite's +0.9% move. With a Zacks Rank #4 (Sell), MET is expected underperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They includeStock #1: A Disruptive Force with Notable Growth and ResilienceStock #2: Bullish Signs Signaling to Buy the DipStock #3: One of the Most Compelling Investments in the MarketStock #4: Leader In a Red-Hot Industry Poised for GrowthStock #5: Modern Omni-Channel Platform Coiled to SpringMost of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.See Our Newest 5 Stocks Set to Double Picks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report MetLife, Inc. (MET): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks